Literature DB >> 33139286

Effect of a Neuropilin-1-Derived Virus Receptor Trap on Enterovirus A71 Infection In Vitro.

Hsiang-Ching Wang1,2, Peng-Nien Huang3,4, Hui-Chen Hung5, Sung-Nien Tseng3, Chia-Chia Chang6, Ya-Ru Tsai5, Yun-Ming Wang7, Shin-Ru Shih3,8, John Tsu-An Hsu9,5.   

Abstract

We discovered that neuropilin 1 (NRP1) is a new receptor candidate to mediate enterovirus A71 (EVA71) into cells. In the engineered form as a decoy receptor, NRP1 was able to recognize and neutralize EVA71 but not enterovirus D68 or coxsackievirus B3 (CVB3). NRP1 recognizes EVA71 through a novel domain on the VP3 capsid protein. The principle in the design, engineering, and refinement of the NRP1-based decoy receptor described in this study represents a general and well-suited antiviral strategy.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  antiviral research; decoy receptor; enterovirus A71; neuropilin 1; virus receptor trap

Year:  2020        PMID: 33139286      PMCID: PMC7927848          DOI: 10.1128/AAC.00695-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Biopharmaceutical benchmarks 2018.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2018-12-06       Impact factor: 54.908

2.  Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.

Authors:  Ken Fujii; Noriyo Nagata; Yuko Sato; Kien Chai Ong; Kum Thong Wong; Seiya Yamayoshi; Midori Shimanuki; Hiroshi Shitara; Choji Taya; Satoshi Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

3.  Identification and characterization of a cross-neutralization epitope of Enterovirus 71.

Authors:  Chia-Chyi Liu; Ai-Hsiang Chou; Shu-Pei Lien; Hsiao-Yu Lin; Shih-Jen Liu; Jui-Yuan Chang; Meng-Shin Guo; Yen-Hung Chow; Wun-Syue Yang; Kate Hsuen-Wen Chang; Charles Sia; Pele Chong
Journal:  Vaccine       Date:  2011-04-16       Impact factor: 3.641

4.  Cell surface nucleolin facilitates enterovirus 71 binding and infection.

Authors:  Pei-Yi Su; Ya-Fang Wang; Sheng-Wen Huang; Yu-Chih Lo; Ya-Hui Wang; Shang-Rung Wu; Dar-Bin Shieh; Shun-Hua Chen; Jen-Ren Wang; Ming-Der Lai; Chuan-Fa Chang
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

5.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

7.  Antiviral Activity of a Llama-Derived Single-Domain Antibody against Enterovirus A71.

Authors:  Peng-Nien Huang; Hsiang-Ching Wang; Hui-Chen Hung; Sung-Nien Tseng; Teng-Yuan Chang; Min-Yuan Chou; Yu-Jen Chen; Yun-Ming Wang; Shin-Ru Shih; John Tsu-An Hsu
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

8.  Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.

Authors:  Hong-Bo Wang; Hua Zhang; Jing-Ping Zhang; Yan Li; Bo Zhao; Guo-Kai Feng; Yong Du; Dan Xiong; Qian Zhong; Wan-Li Liu; Huamao Du; Man-Zhi Li; Wen-Lin Huang; Sai Wah Tsao; Lindsey Hutt-Fletcher; Yi-Xin Zeng; Elliott Kieff; Mu-Sheng Zeng
Journal:  Nat Commun       Date:  2015-02-11       Impact factor: 14.919

9.  Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells.

Authors:  Betsy Yang; Hau Chuang; Kuender D Yang
Journal:  Virol J       Date:  2009-09-15       Impact factor: 4.099

Review 10.  Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy.

Authors:  Chiaho Shih; Chun-Che Liao; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; An-Ting Liou
Journal:  Viruses       Date:  2018-11-28       Impact factor: 5.048

View more
  3 in total

1.  External evaluation of published population pharmacokinetic models of polymyxin B.

Authors:  Ya-Qian Li; Kai-Feng Chen; Jun-Jie Ding; Hong-Yi Tan; Nan Yang; Ya-Qi Lin; Cui-Fang Wu; Yue-Liang Xie; Guo-Ping Yang; Jing-Jing Liu; Qi Pei
Journal:  Eur J Clin Pharmacol       Date:  2021-08-03       Impact factor: 2.953

Review 2.  Neuropilin (NRPs) Related Pathological Conditions and Their Modulators.

Authors:  Matic Broz; Anja Kolarič; Marko Jukič; Urban Bren
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

Review 3.  Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke.

Authors:  Asma W Al-Thomali; Hayder M Al-Kuraishy; Ali I Al-Gareeb; Ali K Al-Buhadiliy; Michel De Waard; Jean-Marc Sabatier; Atif Ali Khan Khalil; Hebatallah M Saad; Gaber El-Saber Batiha
Journal:  Biomedicines       Date:  2022-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.